CCL5 is a potential bridge between type 1 and type 2 inflammation in asthma
Marc Gauthier, Sagar Kale, Timothy B. Oriss, Michael C. Gorry, Richard P. Ramonell, Kathryn R. Dalton, Prabir Ray, John V. Fahy, Max A. Seibold, Mario Castro, Nizar N. Jarjour, Benjamin Gaston, Eugene R. Bleecker, Deborah A. Meyers, Wendy C. Moore, Annette T. Hastie, Elliot Israel, Bruce D. Levy, David T. Mauger, Serpil C. Erzurum, Suzy Comhair, Sally E. Wenzel, Anuradha Ray
Topics & Concepts
AsthmaInflammationType (biology)CCL5MedicineImmunologyBiologyT cellImmune systemIL-2 receptorEcologyAsthma and respiratory diseasesChemokine receptors and signalingChronic Obstructive Pulmonary Disease (COPD) Research